Formulary and Utilization Management

In managed care pharmacy, formulary and utilization management requires collaboration across health care teams (drug review panels, safety committees, medical and pharmacy staff etc.) to ensure the appropriate, safe, and cost-effective use of medications. Our resources provide guidelines, tools, and best practices to help these health care professionals manage drug formularies, optimize medication therapy, and enhance patient care.

P&T Committee - Stock
Health Care Innovation: AMCP’s CEO Looks at the Complex Landscape Around Prescription Drug Costs

AMCP’s CEO Looks at the Complex Landscape Around Prescription Drug Costs

AMCP CEO Susan Cantrell stresses how collaboration is key in addressing challenges such as high drug prices and healthcare disparities. While there’s no silver bullet, solutions such as tailored population benefit design and value-based contracting can play an important role in making a difference for ordinary Americans looking for affordable access to prescriptions.
Formulary & Utilization Management, Drug Pricing, Legislation & Regulation
Health Technology Assessment and Value Assessment Overview

Health Technology Assessment and Value Assessment Frameworks to Inform Coverage Reimbursement

Discover how health technology assessment (HTA) and value assessment frameworks play a crucial role in evaluating pharmaceuticals and health interventions. The recent multistakeholder Partnership Forum, hosted by AMCP, delved into recognizing value within resource constraints. Key takeaways include emphasizing innovative pharmaceutical products, comprehensive data, and the need for trusted value assessments in healthcare decision-making. Explore best practices for enhancing value assessment tools and processes across the industry.
Formulary & Utilization Management, Value Framework, Health Technology, Health Information Technology, Managed Care Practice Issues
AMCP Format 4.1 Teaser Image

AMCP Format for Formulary Submissions — Guidance on Submission of Pre-Approval and Post-Approval Clinical and Economic Information and Evidence, Version 4.1

The aim of the AMCP Format is to identify comprehensive evidence and information elements that meet the evidentiary needs of HCDMs. The AMCP Format is designed to encourage sharing of objective, credible, and relevant information on medical products.
Format for Formulary Submissions, Formulary & Utilization Management
AMCP Format 4.1 Teaser Image

AMCP Format for Formulary Submissions — Guidance on Submission of Pre-Approval and Post-Approval Clinical and Economic Information and Evidence, Version 4.1

The aim of the AMCP Format is to identify comprehensive evidence and information elements that meet the evidentiary needs of HCDMs. The AMCP Format is designed to encourage sharing of objective, credible, and relevant information on medical products.
Formulary & Utilization Management, Format for Formulary Submissions